Proteomics and Genomics Combined With CT to Predict CVD

NCT05800093 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 310

Last updated 2025-10-02

No results posted yet for this study

Summary

This study evaluates plaque progression and characteristics in patients with coronary atherosclerosis.

Conditions

  • Coronary Artery Disease Progression

Sponsors & Collaborators

  • Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

    lead OTHER

Principal Investigators

  • Erik SG Stroes, MD PhD · Amsterdam UMC

Eligibility

Min Age
50 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-12
Primary Completion
2026-01-30
Completion
2026-06-01

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05800093 on ClinicalTrials.gov